Kim Carlson Banning, Ph.D., is a Clinical Regulatory Affairs Specialist at Acumed since September 2021, responsible for writing Clinical Evaluation Plans and Clinical Evaluation Reports in accordance with EU MDR regulations. Prior experience includes a role as a Postdoctoral Researcher at UT Southwestern Medical Center from October 2013 to August 2018, where research focused on the pathogenic behavior of enterohemorrhagic E. coli. Kim served as a Predoctoral Fellow at BCM from August 2007 to August 2013, concentrating on antibiotic-resistant gram-negative bacteria mechanisms. Earlier career experience involved working as a Writing Consultant at the University of Houston from August 2004 to July 2007, aiding students in enhancing their writing skills. Academic credentials include a Ph.D. in Biochemistry and Molecular Biology from Baylor College of Medicine and dual Bachelor of Science degrees in Biochemistry and Biophysical Sciences and Biology from the University of Houston.